BIOMAT Database Logo BIOMAT Database Logo

Oral antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates from Japanese children. 2002

Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Department of Pediatrics, Faculty of Medicine, Kagoshima University, Sakuragaoka 8-35-1, Japan. nishi1@m2.kufm.kagoshima-u.ac.jp

The minimum inhibitory concentrations (MICs) of 11 oral antibiotics were measured for 140 Streptococcus pneumoniae, 115 Haemophilus influenzae, and 46 Moraxella catarrhalis strains isolated from Japanese children. The antibiotics selected included a range of commonly prescribed agents together with a selection of new cefems and a penem. Cefditoren was most active against the highly penicillin resistant S. pneumoniae, beta-lactamase-producing H. influenzae and beta-lactamase-negative ampicillin-resistant H. influenzae. However, amoxycillin retained good activity against the penicillin-susceptible or -intermediately resistant S. pneumoniae (88.6%) and most of ampicillin-susceptible or -intermediately resistant H. influenzae (87.9%). We thus consider that amoxycillin remains a useful initial choice for the treatment of paediatric respiratory infections in Japan.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011008 Pneumococcal Infections Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE. Streptococcus pneumoniae Infections,Infections, Pneumococcal,Infections, Streptococcus pneumoniae,Pneumococcal Diseases,Disease, Pneumococcal,Diseases, Pneumococcal,Infection, Pneumococcal,Infection, Streptococcus pneumoniae,Pneumococcal Disease,Pneumococcal Infection,Streptococcus pneumoniae Infection
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D001936 Moraxella catarrhalis Gram-negative aerobic cocci of low virulence that colonize the nasopharynx and occasionally cause MENINGITIS; BACTEREMIA; EMPYEMA; PERICARDITIS; and PNEUMONIA. Branhamella catarrhalis,Mikrokkokus catarrhalis,Moraxella (Branhamella) catarrhalis
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006192 Haemophilus Infections Infections with bacteria of the genus HAEMOPHILUS. Hemophilus Infections,Haemophilus influenzae Infection,Haemophilus influenzae Type b Infection,Hib Infection,Infections, Haemophilus,Infections, Hemophilus,Haemophilus Infection,Haemophilus influenzae Infections,Hemophilus Infection,Hib Infections,Infection, Haemophilus,Infection, Haemophilus influenzae,Infection, Hemophilus,Infection, Hib
D006193 Haemophilus influenzae A species of HAEMOPHILUS found on the mucous membranes of humans and a variety of animals. The species is further divided into biotypes I through VIII. Bacterium influenzae,Coccobacillus pfeifferi,Haemophilus meningitidis,Hemophilus influenzae,Influenza-bacillus,Mycobacterium influenzae
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents.
June 2001, International journal of antimicrobial agents,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
March 1999, The Journal of antimicrobial chemotherapy,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Determination of anti-microbial susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis.
February 2002, JPMA. The Journal of the Pakistan Medical Association,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: a prospective U.S. study.
November 1999, Antimicrobial agents and chemotherapy,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Increasing antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Finland.
September 1997, The Journal of antimicrobial chemotherapy,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States.
November 1990, Antimicrobial agents and chemotherapy,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in two successive respiratory seasons in the US.
August 2002, International journal of antimicrobial agents,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
September 2004, Journal of the Formosan Medical Association = Taiwan yi zhi,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Susceptibilities of Haemophilus influenzae, Streptococcus pneumoniae, including serotype 19A, and Moraxella catarrhalis paediatric isolates from 2005 to 2007 to commonly used antibiotics.
March 2009, The Journal of antimicrobial chemotherapy,
Junichiro Nishi, and Masao Yoshinaga, and Koichi Tokuda, and Kaori Masuda, and Ryuji Masuda, and Akira Kamenosono, and Kunihiro Manago, and Koichiro Miyata
Antimicrobial susceptibilities of clinical isolates of Haemophilus influenzae and Moraxella catarrhalis collected during 1999-2000 from 13 countries.
December 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases,
Copied contents to your clipboard!